MHRA approves Valneva’s chikungunya vaccine Ixchiq for use in adults
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use in adults. Ixchiq is now the first vaccine approved in the UK to prevent disease caused by the chikungunya virus (CHIKV) in individuals aged 18 years and older.
Chikungunya ‘stooping disease’ explained as UK approves first vaccine
The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The disease strikes around half a million people every year and climate change has increased the risk of transmission in Europe. So what is it and why do we need a vaccine?
At least five suspected cases of chikungunya were recorded in Davao City in January 2025. The residents who were suspected of ...
To note, CHO recorded 12 chikungunya cases across various barangays in the city in 2024, which also included Barangay 9-A. While Chikungunya is not fatal, she stressed that keeping the surroundings ...
Although not listed as a hemorrhagic fever virus ... diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically, symptoms resemble those of dengue ...
6d
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...
The Davao City Health Office is monitoring five suspected cases of chikungunya, with an increase in cases reported in ...
Chikungunya infected children are being reported these days, said Dr. Deepal Perera, a specialist at the Lady Ridgeway ...
Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback